BIO
PLAY_BIO_002

Identity Preserved (IP) Supply & Molecular Segregation

The implementation of a rigid, closed-loop supply chain that ensures biological products remain pure and isolated from 'Non-Target' genetics or contaminants. This maneuver is essential for securing 'Non-GMO' premiums, avoiding 'Biological Adulteration' (BIO_SAF_007), and maintaining 'Regulatory License to Operate' in high-compliance bio-markets.

Bio-Safety Quality Assurance / Strategic Compliance 4 Action Steps

Action Steps

  1. 1 Physical Decoupling: Deploy dedicated 'Sovereign Silos' and sealed containerized transport (LI08) to prevent physical mixing at transshipment points.
  2. 2 Molecular Gatekeeping: Mandate 'Rapid DNA/Sequencing' at every handover point to verify that the batch matches the 'Digital Product Passport' (DT05) signature.
  3. 3 Temporal Separation: In shared processing facilities, implement 'Clean-Break' protocols where IP batches are processed only after a deep-system sterilization (SC01).
  4. 4 Verification Arbitrage: Utilize the verified 'Purity Certificate' to bypass 2026 'Bio-Safety Inspection' delays at international borders (GEO_CMP_002).

Feasibility Checks

Attribute thresholds that must be met for this playbook to be viable

SC05 Certification & Verification Authority
≤ 2
DT05 Traceability Fragmentation & Provenance Risk
≤ 2
LI01 Logistical Friction & Displacement Cost
≥ 3

Trigger Rules

Risk conditions that activate this playbook

BIO_SAF_003 3 conditions
EMA Food Fraud
BIO_SAF_006 3 conditions
Invasive Species Loss
BIO_SAF_007 3 conditions
Antibiotic Ban
GEO_CMP_003 3 conditions
Forced Labor Ban (UFLPA/EUFLR)

Implements Strategies

This playbook contributes to 2 strategic frameworks:

Differentiation Supply Chain Resilience